Brief: Medincell FY Net Loss Widens To EUR 29.5 Million

Medincell SA

26/06/2023 18:01

June 26 (Reuters) - Medincell SA  MEDCL.PA :
    * CONSOLIDATED FY 2023 FINANCIALS
    * FY INCOME FROM ORDINARY ACTIVITIES: EUR 13.7 MILLION, +64%
VERSUS PREVIOUS YEAR
    * FY OPERATING EXPENSES: EUR 37.7 MILLION, +14% VERSUS
PREVIOUS
YEAR,74% OF EXPENSES ARE DEVOTED TO RESEARCH AND DEVELOPMENT
    * ON MARCH 31, 2023, MEDINCELL HAD EUR 6.5 MILLION OF CASH
AND
CASH EQUIVALENTS
    * FY CASH CONSUMPTION FROM OPERATING ACTIVITIES: EUR 21.2
MILLION,
-1% VERSUS PREVIOUS YEAR
    * IN ADDITION, RECENT CAPITAL RAISE PROVIDES US CASH
VISIBILITY
BEYOND MDC-TJK AND MDC-CWM PHASE 3 KEY RESULTS.
    * CONSIDERING THESE FINANCING OPERATIONS AND ANTICIPATED
REVENUES
FROM EXISTING COLLABORATION, MEDINCELL HAS RESOURCES TO CONTINUE
ITS PORTFOLIO DEVELOPMENT
    * FY CURRENT OPERATING LOSS EUR 24.03 MILLION VERSUS LOSS
EUR 23.8
MILLION YEAR AGO
    * FY NET LOSS EUR 29.5 MILLION VERSUS LOSS EUR 24.8 MILLION
YEAR
AGO

Source text for Eikon:  ID:nBw1yS21ba 
Further company coverage:  MEDCL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))